Showing results (11-20 of 107) with videos related to

Sort By:
Pageof 11
International Journal of Environmental Research and Public Health|April 12, 2022
Has the Volume-Based Drug Purchasing Approach Achieved Equilibrium among Various Stakeholders? Evidence from ChinaQian Xing, Wenxi Tang, Mingyang Li, et al.
Plos One|November 3, 2022
A study on the performance and cost-effectiveness of robots in replacing manual nucleic acid collection method: Experience from the COVID-19 pandemicZhuoyuan Chi, Yusi Tu, Fangfang Gong, et al.
Frontiers in Immunology|November 17, 2022
A systematic review and network meta-analysis of first-line immune checkpoint inhibitor combination therapies in patients with advanced non-squamous non-small cell lung cancerTaihang Shao, Mingye Zhao, Leyi Liang, et al.
Health Economics Review|April 11, 2025
Safety, efficacy, and cost-effectiveness evaluation of systemic treatments for refractory colorectal cancer: a systematic review and modeling studyMingye Zhao, Yunlin Jiang, Taihang Shao, et al.
BMC Health Services Research|April 26, 2019
Satisfaction with service coverage and drug list may influence patients' acceptance of general practitioner contract service: a cross-sectional study in Guangdong, ChinaAiyun Chen, Shanshan Feng, Wenxi Tang, et al.
Frontiers in Public Health|September 1, 2022
Cost-effectiveness analysis of camrelizumab plus chemotherapy as first-line treatment for advanced squamous NSCLC in ChinaTaihang Shao, Yinan Ren, Mingye Zhao, et al.
Clinicoeconomics and Outcomes Research : CEOR|December 28, 2018
Indirect costs associated with premature mortality among those with veno-occlusive disease/sinusoidal obstruction syndrome with multiorgan dysfunction post-hematopoietic stem-cell-transplantZheng-Yi Zhou, Wenxi Tang, Kathleen F Villa
International Journal of Environmental Research and Public Health|February 15, 2022
Effectiveness and Cost-Effectiveness of Non-Pharmacological Interventions among Chinese Adults with Prediabetes: A Protocol for Network Meta-Analysis and CHIME-Modeled Cost-Effectiveness AnalysisYue Yin, Yusi Tu, Mingye Zhao, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|February 25, 2023
Serplulimab Plus Chemotherapy vs Chemotherapy for Treatment of US and Chinese Patients with Extensive-Stage Small-Cell Lung Cancer: A Cost-Effectiveness Analysis to Inform Drug PricingTaihang Shao, Mingye Zhao, Leyi Liang, et al.
BMC Cancer|July 2, 2025
Racial, ethnic, sex, and age representation in clinical trials of radiopharmaceutical tumor therapy: a systematic review and meta-analysisMingye Zhao, Yunlin Jiang, Taihang Shao, et al.
Pageof 11